Where breast surgery revenue slips: bilateral coding, global periods, and node reporting Breast surgery claims lose money in three places: bilateral procedures billed without the right modifier, post-op visits billed inside a 90-day global period, and sentinel node work coded against the wrong primary procedure. Qualigenix codes and bills breast surgery for independent surgeons, surgical oncology groups and breast centers, with 98.9% coding accuracy across the charts its specialty coders handle.
Breast surgery billing takes operative coding that matches the op note and pathology report, laterality and bilateral modifiers on every claim, global-period tracking from biopsy through reconstruction, and authorization before mastectomy, breast MRI and inpatient stays. Qualigenix runs all of it for breast surgery practices, with a 98.2% first-pass clean claim rate on first submission. Start with a free billing audit at 786-259-0231.
The breast code set splits procedures by technique and extent. A lumpectomy is 19301, a lumpectomy with axillary lymphadenectomy is 19302, and billing 19301 plus a separate axillary dissection code where 19302 applies will trip an NCCI edit. Image-guided biopsies are coded per lesion, so a second lesion takes the add-on code instead of a repeat of the primary.
Commercial and Medicare Advantage plans often require prior authorization for mastectomy, reconstruction, breast MRI and inpatient admission. Prophylactic mastectomy draws extra review, since payers want the genetic test result and risk assessment in the record. A case performed on an expired or mismatched authorization is often denied outright, and retro-authorization is not always available.
Under the Medicare fee schedule, breast biopsies and localization devices carry 0-day global periods, while lumpectomy and mastectomy carry 90-day global periods. Post-op visits inside that window are paid as part of the surgery. An unrelated visit needs modifier 24, the decision-for-surgery visit before a major procedure needs 57, and a planned re-excision for positive margins needs 58. Missing one turns a payable service into a denial or a later recoupment.
Modifier 62 applies when two surgeons of different specialties each perform a distinct part of one CPT code, and Medicare pays each co-surgeon 62.5% of the fee schedule amount. Assistant-at-surgery claims (modifier 80 or 82) pay 16%, and only on codes the fee schedule allows an assistant for. Payers deny both when the op notes don't show each surgeon's role.
The Women's Health and Cancer Rights Act of 1998 requires group health plans that cover mastectomy to cover reconstruction, surgery on the other breast for symmetry, prostheses, and treatment of complications such as lymphedema. Plans can still apply deductibles, coinsurance and authorization rules, so coverage needs checking before the first stage.
Breast coding depends on what the op note and pathology report state: lesion count, guidance type, node technique, margin status and laterality. A note that says "sentinel node biopsy" without saying whether dye, radiotracer or both were used leaves the coder choosing between codes on guesswork.
NCCI edits pair many breast codes with the services they already include, such as imaging guidance inside a biopsy code or the node dissection inside 19302 and 19307. Modifier 59 or XS overrides those edits only when the record shows a separate site or session. Routine use of 59 is a known audit flag.
In the 2025 CMS CERT data for general surgery, the Medicare provider type many breast surgeons bill under, documentation gaps accounted for 60.2% of improper payments and coding errors for the other 39.8%. Both are problems a billing team can catch before the claim leaves.
Qualigenix assigns breast surgery claims to coders who work surgical specialties, and each gap above has a matching control.
Coders read the op note and pathology report before assigning codes, so the choice between 19301 and 19302, lesion add-ons and node codes matches the record. Qualigenix holds 98.9% coding accuracy and keeps its over- and undercoding rate under 2%.
The authorization team requests approval as soon as surgery is scheduled, tracks it to a decision, and checks that the CPT codes, laterality and dates on the approval match the planned case.
Every surgical claim opens a global-period window. Visits and procedures inside it are checked for modifier 24, 25, 57, 58, 78 or 79 before they go out.
For shared cases, the team checks each surgeon's codes and modifiers against both op notes and confirms co-surgery and assistant eligibility by code and by payer.
Eligibility, deductibles, coinsurance and reconstruction coverage are verified before the first stage, so the practice knows what the plan will pay before the patient is on the schedule.
When a note is missing laterality, lesion count or node technique, coders query the surgeon before billing. A query takes minutes. A denial takes weeks.
Denied claims are sorted by root cause and appealed with the op note, pathology report and authorization attached. Qualigenix overturns 79% of the denials it works, with an average appeal turnaround under 9 days.
Coding is reviewed against current NCCI edits, modifier rules and global-period policy, and Qualigenix holds a 98.6% compliance and audit pass rate.
Bilateral mastectomy and biopsy procedures were billed without modifier 50, so payers paid only one side, while sentinel-node injection and biopsy (38792/38525) and localization-device placement (19281-19288) add-ons went under-reported, holding reimbursement below the work performed.
We applied modifier 50 on bilateral procedures, captured sentinel-node and axillary dissection codes, reported localization and image-guidance add-ons, and reconciled all services to the operative note.
Image-guided biopsy (19083/19085) and lumpectomy (19301/19302) claims aged after a coding-staff gap, with assistant-surgeon (modifier 80) and localization-device charges left unbilled.
We cleared the backlog, captured assistant-surgeon and localization add-on charges, corrected biopsy device coding, and set a submission cadence tied to the OR schedule.
Mastectomy, reconstruction, and breast MRI were scheduled before authorization and inpatient-status approval, so the highest-dollar operative and imaging claims denied for missing auth.
We secured authorization and inpatient-status confirmation before scheduling, coordinated reconstruction co-surgeon approvals, and tracked medical-necessity documentation.
Each breast service line has its own code family, global period and documentation trigger.
Codes 19081–19086 report percutaneous breast biopsy with imaging guidance and clip placement: stereotactic (19081, 19082), ultrasound (19083, 19084) and MRI (19085, 19086). The first lesion takes the primary code and each added lesion takes the add-on. A biopsy without imaging uses 19100, and an open incisional biopsy uses 19101.
Qualigenix keeps breast surgery billing compliant by coding to the op note and pathology report, applying NCCI edits and global-period rules as written, and checking every bilateral, co-surgery and staged-procedure modifier against the documentation. Underbilling a mastectomy with sentinel node work leaves money unpaid. Overbilling it with unsupported modifiers invites recoupment. Qualigenix holds a 98.6% compliance and audit pass rate, with an over- and undercoding rate under 2%. All work is HIPAA compliant, and patient records are handled under strict security controls.

Pricing depends on claim volume, case mix and the scope of services, and outsourced billing is usually priced as a percentage of collections or per claim. Qualigenix quotes after a free billing review of your current claims.
Yes. A lumpectomy (19301) with sentinel node biopsy is billed with 38525, plus 38900 when dye mapping is documented. When a full axillary dissection is done with the lumpectomy, 19302 is used instead and the dissection is not billed separately.
Yes. Qualigenix checks reconstruction benefits, deductibles and authorization rules before the first stage, since the Women's Health and Cancer Rights Act requires coverage but plans still apply cost sharing.
Yes. Qualigenix works existing A/R alongside new claims, and across its practices it has reduced days in A/R from 54 to 36.
For Medicare, a bilateral mastectomy is billed on one line with modifier 50 and paid at 150% of the single-side amount. Some commercial payers want two lines with RT and LT instead, so Qualigenix bills to each payer's rule.
Routine post-op visits inside the 90-day global period are included in the surgical payment and are not billed. Unrelated visits get modifier 24, and a planned re-excision gets modifier 58, both supported by the note.
Most likely. Qualigenix supports 133 EMR/EHR platforms and works inside your existing system.
Average onboarding takes 6 days. Most practices start with a free billing audit.